Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Institute for Clinical and Experimental Medicine
St. Jude Children's Research Hospital
The University of Texas Health Science Center at San Antonio
Emory University
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
University of Chicago
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
University of Washington
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
University of Southern California
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Colorado, Denver
University of Chicago
National Cancer Institute (NCI)